Placental Mesenchymal Stromal Cells Rescue Ambulation in Ovine Myelomeningocele
Tóm tắt
Myelomeningocele (MMC)—commonly known as spina bifida—is a congenital birth defect that causes lifelong paralysis, incontinence, musculoskeletal deformities, and severe cognitive disabilities. The recent landmark Management of Myelomeningocele Study (MOMS) demonstrated for the first time in humans that in utero surgical repair of the MMC defect improves lower limb motor function, suggesting a capacity for improved neurologic outcomes in this disorder. However, functional recovery was incomplete, and 58% of the treated children were unable to walk independently at 30 months of age. In the present study, we demonstrate that using early gestation human placenta-derived mesenchymal stromal cells (PMSCs) to augment in utero repair of MMC results in significant and consistent improvement in neurologic function at birth in the rigorous fetal ovine model of MMC. In vitro, human PMSCs express characteristic MSC markers and trilineage differentiation potential. Protein array assays and enzyme-linked immunosorbent assay show that PMSCs secrete a variety of immunomodulatory and angiogenic cytokines. Compared with adult bone marrow MSCs, PMSCs secrete significantly higher levels of brain-derived neurotrophic factor and hepatocyte growth factor, both of which have known neuroprotective capabilities. In vivo, functional and histopathologic analysis demonstrated that human PMSCs mediate a significant, clinically relevant improvement in motor function in MMC lambs and increase the preservation of large neurons within the spinal cord. These preclinical results in the well-established fetal ovine model of MMC provide promising early support for translating in utero stem cell therapy for MMC into clinical application for patients.
This study presents placenta-derived mesenchymal stromal cell (PMSC) treatment as a potential therapy for myelomeningocele (MMC). Application of PMSCs can augment current in utero surgical repair in the well-established and rigorously applied fetal lamb model of MMC. Treatment with human PMSCs significantly and dramatically improved neurologic function and preserved spinal cord neuron density in experimental animals. Sixty-seven percent of the PMSC-treated lambs were able to ambulate independently, with two exhibiting no motor deficits whatsoever. In contrast, none of the lambs treated with the vehicle alone were capable of ambulation. The locomotor rescue demonstrated in PMSC-treated lambs indicates great promise for future clinical trials to improve paralysis in children afflicted with MMC.
Từ khóa
Tài liệu tham khảo
Coran, Expert Consult-Online and Print
Ouyang, 2007, Health care expenditures of children and adults with spina bifida in a privately insured U.S. population, Birth Defects Res A Clin Mol Teratol, 79, 552, 10.1002/bdra.20360
Parker, 2010, Updated national birth prevalence estimates for selected birth defects in the United States, 2004-2006, Birth Defects Res A Clin Mol Teratol, 88, 1008, 10.1002/bdra.20735
Adzick, 2011, A randomized trial of prenatal versus postnatal repair of myelomeningocele, N Engl J Med, 364, 993, 10.1056/NEJMoa1014379
Flake, 2004, In utero stem cell transplantation, Best Pract Res Clin Obstet Gynaecol, 18, 941, 10.1016/j.bpobgyn.2004.06.006
Tiblad, 2008, Fetal stem-cell transplantation, Best Pract Res Clin Obstet Gynaecol, 22, 189, 10.1016/j.bpobgyn.2007.07.007
Liang, 2014, Paracrine mechanisms of mesenchymal stem cell-based therapy: Current status and perspectives, Cell Transplant, 23, 1045, 10.3727/096368913X667709
Guillot, 2007, Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC, Stem Cells, 25, 646, 10.1634/stemcells.2006-0208
Portmann-Lanz, 2006, Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration, Am J Obstet Gynecol, 194, 664, 10.1016/j.ajog.2006.01.101
Murphy, 2013, Amniotic fluid and placental membranes: Unexpected sources of highly multipotent cells, Semin Reprod Med, 31, 62, 10.1055/s-0032-1331799
Lankford, 2015, Early gestation chorionic villi-derived stromal cells for fetal tissue engineering, World J Stem Cells, 7, 195, 10.4252/wjsc.v7.i1.195
Lee, 2012, Comparison of immunomodulatory effects of placenta mesenchymal stem cells with bone marrow and adipose mesenchymal stem cells, Int Immunopharmacol, 13, 219, 10.1016/j.intimp.2012.03.024
Calzarossa, 2013, Neurorescue effects and stem properties of chorionic villi and amniotic progenitor cells, Neuroscience, 234, 158, 10.1016/j.neuroscience.2012.12.038
Jones, 2012, Ontological differences in first compared to third trimester human fetal placental chorionic stem cells, PLoS One, 7, e43395, 10.1371/journal.pone.0043395
Roselli, 2013, Fetal mesenchymal stromal cells from cryopreserved human chorionic villi: Cytogenetic and molecular analysis of genome stability in long-term cultures, Cytotherapy, 15, 1340, 10.1016/j.jcyt.2013.06.019
Poloni, 2008, Characterization and expansion of mesenchymal progenitor cells from first-trimester chorionic villi of human placenta, Cytotherapy, 10, 690, 10.1080/14653240802419310
von Koch, 2005, Myelomeningocele: Characterization of a surgically induced sheep model and its central nervous system similarities and differences to the human disease, Am J Obstet Gynecol, 193, 1456, 10.1016/j.ajog.2005.02.110
Meuli, 1997, The spinal cord lesion in human fetuses with myelomeningocele: Implications for fetal surgery, J Pediatr Surg, 32, 448, 10.1016/S0022-3468(97)90603-5
Brown, 2015, Development of a locomotor rating scale for testing motor function in sheep, J Pediatr Surg, 50, 617, 10.1016/j.jpedsurg.2015.01.002
Gensel, 2006, Behavioral and histological characterization of unilateral cervical spinal cord contusion injury in rats, J Neurotrauma, 23, 36, 10.1089/neu.2006.23.36
Delcroix, 2010, EGF and bFGF pre-treatment enhances neural specification and the response to neuronal commitment of MIAMI cells, Differentiation, 80, 213, 10.1016/j.diff.2010.07.001
Dominici, 2006, Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement, Cytotherapy, 8, 315, 10.1080/14653240600855905
Deng, 2006, Mesenchymal stem cells spontaneously express neural proteins in culture and are neurogenic after transplantation, Stem Cells, 24, 1054, 10.1634/stemcells.2005-0370
Nieto, 2002, The snail superfamily of zinc-finger transcription factors, Nat Rev Mol Cell Biol, 3, 155, 10.1038/nrm757
Kim, 2003, SOX10 maintains multipotency and inhibits neuronal differentiation of neural crest stem cells, Neuron, 38, 17, 10.1016/S0896-6273(03)00163-6
Sarkar, 2013, The sox family of transcription factors: Versatile regulators of stem and progenitor cell fate, Cell Stem Cell, 12, 15, 10.1016/j.stem.2012.12.007
Isenmann, 2009, TWIST family of basic helix-loop-helix transcription factors mediate human mesenchymal stem cell growth and commitment, Stem Cells, 27, 2457, 10.1002/stem.181
Yoshizawa, 2003, Fetal surgery for repair of myelomeningocele allows normal development of the rectum in sheep, Pediatr Surg Int, 19, 162, 10.1007/s00383-002-0910-4
Farmer, 2003, In utero repair of myelomeningocele: Experimental pathophysiology, initial clinical experience, and outcomes, Arch Surg, 138, 872, 10.1001/archsurg.138.8.872
Saadai, 2011, Prenatal repair of myelomeningocele with aligned nanofibrous scaffolds—A pilot study in sheep, J Pediatr Surg, 46, 2279, 10.1016/j.jpedsurg.2011.09.014
Saadai, 2013, Human induced pluripotent stem cell-derived neural crest stem cells integrate into the injured spinal cord in the fetal lamb model of myelomeningocele, J Pediatr Surg, 48, 158, 10.1016/j.jpedsurg.2012.10.034
Brown, 2014, In utero repair of myelomeningocele with autologous amniotic membrane in the fetal lamb model, J Pediatr Surg, 49, 133, 10.1016/j.jpedsurg.2013.09.043
Genbacev, 2011, Establishment of human trophoblast progenitor cell lines from the chorion, Stem Cells, 29, 1427, 10.1002/stem.686
Bačenková, 2011, Isolation and basic characterization of human term amnion and chorion mesenchymal stromal cells, Cytotherapy, 13, 1047, 10.3109/14653249.2011.592522
Alfirevic, 2009, Amniocentesis and chorionic villus sampling for prenatal diagnosis, Cochrane Database Syst Review, CD003252
Vellasamy, 2012, Isolation and characterisation of mesenchymal stem cells derived from human placenta tissue, World J Stem Cells, 4, 53, 10.4252/wjsc.v4.i6.53
Meuli, 1995, In utero surgery rescues neurological function at birth in sheep with spina bifida, Nat Med, 1, 342, 10.1038/nm0495-342
Fauza, 2008, Neural stem cell delivery to the spinal cord in an ovine model of fetal surgery for spina bifida, Surgery, 144, 367, 10.1016/j.surg.2008.05.009
Korenromp, 1986, Early fetal leg movements in myelomeningocele, Lancet, 1, 917, 10.1016/S0140-6736(86)91022-6
Adzick, 2012, Fetal surgery for myelomeningocele: Trials and tribulations. Isabella Forshall Lecture, J Pediatr Surg, 47, 273, 10.1016/j.jpedsurg.2011.11.021
Stiefel, 2007, Scanning electron microscopy of fetal murine myelomeningocele reveals growth and development of the spinal cord in early gestation and neural tissue destruction around birth, J Pediatr Surg, 42, 1561, 10.1016/j.jpedsurg.2007.04.019
Barlow, 2008, Comparison of human placenta- and bone marrow-derived multipotent mesenchymal stem cells, Stem Cells Dev, 17, 1095, 10.1089/scd.2007.0154
Hass, 2011, Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC, Cell Commun Signal, 9, 12, 10.1186/1478-811X-9-12
Martinez, 2014, Neurotrauma and mesenchymal stem cells treatment: From experimental studies to clinical trials, World J Stem Cells, 6, 179, 10.4252/wjsc.v6.i2.179
Bussolino, 1992, Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth, J Cell Biol, 119, 629, 10.1083/jcb.119.3.629
Yancopoulos, 2000, Vascular-specific growth factors and blood vessel formation, Nature, 407, 242, 10.1038/35025215
Maina, 1999, Hepatocyte growth factor, a versatile signal for developing neurons, Nat Neurosci, 2, 213, 10.1038/6310
Bai, 2012, Hepatocyte growth factor mediates mesenchymal stem cell–induced recovery in multiple sclerosis models, Nat Neurosci, 15, 862, 10.1038/nn.3109
Lu, 2014, BDNF and synaptic plasticity, cognitive function, and dysfunction, Handbook Exp Pharmacol, 220, 223, 10.1007/978-3-642-45106-5_9
Weishaupt, 2012, BDNF: The career of a multifaceted neurotrophin in spinal cord injury, Exp Neurol, 238, 254, 10.1016/j.expneurol.2012.09.001
Tejima, 2009, Neuroprotective effects of overexpressing tissue inhibitor of metalloproteinase TIMP-1, J Neurotrauma, 26, 1935, 10.1089/neu.2009.0959
Souvenir, 2011, Tissue inhibitor of matrix metalloproteinase-1 mediates erythropoietin-induced neuroprotection in hypoxia ischemia, Neurobiol Dis, 44, 28, 10.1016/j.nbd.2011.05.020
Quertainmont, 2012, Mesenchymal stem cell graft improves recovery after spinal cord injury in adult rats through neurotrophic and pro-angiogenic actions, PLoS ONE, 7, e39500, 10.1371/journal.pone.0039500